STREAM BIOENERGY UK LIMITED

Company Registration Number:
13402289 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2023

Period of accounts

Start date: 01 January 2023

End date: 31 December 2023

STREAM BIOENERGY UK LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2023

Balance sheet
Notes

STREAM BIOENERGY UK LIMITED

Balance sheet

As at 31 December 2023


Notes

2023

2022


£

£
Called up share capital not paid: 1,000 1,000
Fixed assets
Tangible assets: 3 528,403 100,387
Investments: 4 22,385,024 20,484,825
Total fixed assets: 22,913,427 20,585,212
Current assets
Debtors: 5 4,676,643 2,199,666
Cash at bank and in hand: 50,280 27,612
Total current assets: 4,726,923 2,227,278
Creditors: amounts falling due within one year: 6 (1,576,608) (537,407)
Net current assets (liabilities): 3,150,315 1,689,871
Total assets less current liabilities: 26,064,742 22,276,083
Creditors: amounts falling due after more than one year: 7 (27,992,661) (23,094,880)
Total net assets (liabilities): (1,927,919) (818,797)
Capital and reserves
Called up share capital: 10 10
Share premium account: 990 990
Profit and loss account: (1,928,919) (819,797)
Shareholders funds: (1,927,919) (818,797)

The notes form part of these financial statements

STREAM BIOENERGY UK LIMITED

Balance sheet statements

For the year ending 31 December 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 24 June 2024
and signed on behalf of the board by:

Name: Kevin Fitzduff
Status: Director

The notes form part of these financial statements

STREAM BIOENERGY UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

STREAM BIOENERGY UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

2. Employees

2023 2022
Average number of employees during the period 22 16

STREAM BIOENERGY UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

3. Tangible Assets

Total
Cost £
At 01 January 2023 100,387
Additions 428,016
At 31 December 2023 528,403
Net book value
At 31 December 2023 528,403
At 31 December 2022 100,387

STREAM BIOENERGY UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

4. Fixed investments

Investment in group undertakings £101 Loans to group undertakings £22,384,923

STREAM BIOENERGY UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

5. Debtors

2023 2022
££
Debtors due after more than one year: 0 0

STREAM BIOENERGY UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

6. Creditors: amounts falling due within one year note

Other taxes and social security costs £56,171 Creditors and accruals £1,520,437

STREAM BIOENERGY UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

7. Creditors: amounts falling due after more than one year note

8% Secured Loan Notes 2027 - £24,149,000 8% Secured A Loan PIK Notes 2027 - £1,845,880 Loan interest - £1,997,781

STREAM BIOENERGY UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

8. Post balance sheet events

There were no significant events between the balance sheet date and the date of signing of the financial statements, affecting the company, which require adjustment to or disclosure in the financial statements.